Jasper Therapeutics (JSPR) Misses Q4 EPS by 32c
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Join SI Premium – FREE
Jasper Therapeutics (NASDAQ: JSPR) reported Q4 EPS of ($0.32).
For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
- Walmart (WMT) PT Lowered to $135 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
